Exploring Portugal’s Clinical Trials Landscape: Innovations, Infrastructure, and Opportunities Portugal stands as a strategic choice for conducting clinical trials, offering a unique blend of opportunities for the global healthcare and pharmaceutical industries. With a population of over 10 million, Portugal boasts a high-quality healthcare system integrated with advanced research facilities and a well-educated medical community. Despite its smaller size, Portugal’s diverse demographic and genetic Read more
7 Reasons to Choose Central and Eastern Europe as Your Go-To Destination for Clinical Trials The global market for CROs is booming, projected to grow from $52.19 billion in 2023 to approximately $68.92 billion by 2027 (link to the source). Despite this, many clinical trials face significant delays, with 80% running over a month behind schedule, leading to substantial financial losses. These challenges often require rapid, effective strategies to rescue Read more
Clinical Research Focus. 32nd Edition Poland: Europe’s New Hub for Clinical Research Poland has rapidly become a top destination for biotechnology professionals, drawn by its dynamic setting conducive to conducting clinical trials. This growth is underpinned by the nation’s robust healthcare infrastructure, a highly skilled workforce, a supportive regulatory framework, and favorable economic conditions, all combining to create an ideal Read more
New Study Raises Concerns Over Ozempic’s Potential Link to Suicidal Thoughts A recent study published in the Journal of the American Medical Association (JAMA) has brought to light potential safety concerns surrounding Novo Nordisk’s popular diabetes and weight loss drug, Ozempic (semaglutide). The study indicates a possible association between Ozempic and an increased risk of suicidal ideation, adding to the ongoing debate over the safety of Read more
